H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Clearside Biomedical (CLSD - Research Report) today and set a price target of $5.00. The company's shares closed yesterday at $1.61.According to TipRanks, Chen is an analyst with an average return of -10.2% and a 34.89% success rate. Chen covers the Healthcare sector, focusing on stocks such as Veru, Prophase Labs, and Stealth Biotherapeutics.In addition to H.C. Wainwright, Clearside Biomedical also received a Buy from JMP Securities's Jonathan Wolleben in a report issued today. However, yesterday, Needham maintained a Hold rating on Clearside Biomedical (NASDAQ: CLSD).
https://www.tipranks.com/news/blurbs/clearside-biomedical-clsd-gets-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Clearside Biomedical Charts.
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Clearside Biomedical Charts.